Page last updated: 2024-11-06

prednisolone and Malignant Mesothelioma

prednisolone has been researched along with Malignant Mesothelioma in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Okamoto, S1
Tsuboi, H1
Sato, R1
Terasaki, M1
Terasaki, T1
Toko, H1
Shimizu, M1
Honda, F1
Yagishita, M1
Ohyama, A1
Kurata, I1
Abe, S1
Takahashi, H1
Osada, A1
Hagiwara, S1
Kondo, Y1
Matsumoto, I1
Sumida, T1

Reviews

1 review available for prednisolone and Malignant Mesothelioma

ArticleYear
IgG4-related pleural disease with aortitis and submandibular glands involvement successfully treated with corticosteroid: case-based review.
    Rheumatology international, 2020, Volume: 40, Issue:10

    Topics: Adult; Aged; Aortitis; Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunoglobulin G4-R

2020